Research has shown that certain polymorphisms in the ACP1 gene are associated with an increased risk of bone necrosis in children undergoing treatment for acute lymphoblastic leukaemia, indicating a potential role for ACP1 in the pathogenesis of bone necrosis [89, 90]. The gene discussed is ACP1; the disease is acute lymphoblastic leukemia.